Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis

Author： Sinha U.   Ku P.   Malinowski J.   Zhu B.Y.   Scarborough R.M.   Marlowe C.K.   Wong P.W.   Lin P.H.   Hollenbach S.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.395, Iss.1, 2000-04, pp. : 51-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

By Eriksson Bengt I.  

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 1-22

Adis International

Access to resources Recommend Favorite

Thrombin Inhibitors and Anti-Factor Xa Agents in the Treatment of Arterial Occlusion

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1285-1290

Bentham Science Publishers

Access to resources Recommend Favorite

New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes

By Romualdi Erica   Ageno Walter  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 495-505

Informa Healthcare

Access to resources Recommend Favorite